FDG PET to Diagnose Neurolymphomatosis in a Case of Triple-Hit B-Cell Lymphoma

A 46-year-old man with stage IV triple-hit B-cell lymphoma diagnosed in February 2016 was treated with chemotherapy. He was followed classically with FDG PET/CT, which assessed the complete metabolic response in June 2016. In July 2016, he had autologous stem cell transplantation. Two months later,...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine Vol. 42; no. 6; p. 458
Main Authors: Bund, Caroline, Heimburger, Céline, Trensz, Philippe, Fohrer, Cécile, Kremer, Stéphane, Namer, Izzie-Jacques
Format: Journal Article
Language:English
Published: United States 01.06.2017
Subjects:
Animals
Fluorodeoxyglucose F18
Humans
Lymphoma, B-Cell - complications
Lymphoma, B-Cell - pathology
Magnetic Resonance Imaging
Male
Marek Disease - complications
Marek Disease - diagnostic imaging
Middle Aged
Neoplasm Staging
Positron Emission Tomography Computed Tomography
ISSN:1536-0229, 1536-0229
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 46-year-old man with stage IV triple-hit B-cell lymphoma diagnosed in February 2016 was treated with chemotherapy. He was followed classically with FDG PET/CT, which assessed the complete metabolic response in June 2016. In July 2016, he had autologous stem cell transplantation. Two months later, he underwent an FDG PET/CT for revaluation. It showed intense FDG uptake in the medullary canal from cervical 4 to thoracic 4, bilateral cervical 7 to thoracic 8, and right thoracic 9 to 12 nerve roots, leading to the diagnosis of neurolymphomatosis. A clinical cervical radiculopathy and spinal MRI results reinforced this diagnosis.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1536-0229
1536-0229
DOI:10.1097/RLU.0000000000001608